ONC

BeiGene Ltd
D

ONC

255.64
USD
10.98
(4.49%)
مغلق
حجم التداول
22,144
الربح لكل سهم
2
العائد الربحي
-
P/E
-70
حجم السوق
27,665,440,644
المقالات

العنوان: BeOne Medicines Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies witha contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.